Global and United States Myeloid Cells Targeting Therapeutics Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Myeloid Cells Targeting Therapeutics Market
This report focuses on global and United States Myeloid Cells Targeting Therapeutics market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Myeloid Cells Targeting Therapeutics market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Intravenous Injection accounting for % of the Myeloid Cells Targeting Therapeutics global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Oncological Disorders was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Myeloid Cells Targeting Therapeutics market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Myeloid Cells Targeting Therapeutics Scope and Market Size
Myeloid Cells Targeting Therapeutics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Myeloid Cells Targeting Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Myeloid Cells Targeting Therapeutics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Intravenous Injection
    Oral

Segment by Application
    Oncological Disorders
    Rare Disorders

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    ChemoCentryx
    Daiichi Sankyo
    Gilead Sciences
    Janssen Biotech
    Roche
    Pfizer
    GlaxoSmithKline
    Macrophage Pharma
    Enlivex
    Immune-Onc Therapeutics
    Infinity Pharmaceuticals
    AstraZeneca

 1 Study Coverage
    1.1 Myeloid Cells Targeting Therapeutics Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Myeloid Cells Targeting Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Myeloid Cells Targeting Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Myeloid Cells Targeting Therapeutics Market Size for the Year 2017-2028
    1.3 Myeloid Cells Targeting Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Myeloid Cells Targeting Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Myeloid Cells Targeting Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Myeloid Cells Targeting Therapeutics Market Dynamics
        1.4.1 Myeloid Cells Targeting Therapeutics Industry Trends
        1.4.2 Myeloid Cells Targeting Therapeutics Market Drivers
        1.4.3 Myeloid Cells Targeting Therapeutics Market Challenges
        1.4.4 Myeloid Cells Targeting Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Myeloid Cells Targeting Therapeutics by Type
    2.1 Myeloid Cells Targeting Therapeutics Market Segment by Type
        2.1.1 Intravenous Injection
        2.1.2 Oral
    2.2 Global Myeloid Cells Targeting Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Myeloid Cells Targeting Therapeutics Market Size by Type (2017-2028)
    2.4 United States Myeloid Cells Targeting Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Myeloid Cells Targeting Therapeutics Market Size by Type (2017-2028)

 3 Myeloid Cells Targeting Therapeutics by Application
    3.1 Myeloid Cells Targeting Therapeutics Market Segment by Application
        3.1.1 Oncological Disorders
        3.1.2 Rare Disorders
    3.2 Global Myeloid Cells Targeting Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Myeloid Cells Targeting Therapeutics Market Size by Application (2017-2028)
    3.4 United States Myeloid Cells Targeting Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Myeloid Cells Targeting Therapeutics Market Size by Application (2017-2028)

 4 Global Myeloid Cells Targeting Therapeutics Competitor Landscape by Company
    4.1 Global Myeloid Cells Targeting Therapeutics Market Size by Company
        4.1.1 Top Global Myeloid Cells Targeting Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Myeloid Cells Targeting Therapeutics Revenue by Player (2017-2022)
    4.2 Global Myeloid Cells Targeting Therapeutics Concentration Ratio (CR)
        4.2.1 Myeloid Cells Targeting Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Myeloid Cells Targeting Therapeutics in 2021
        4.2.3 Global Myeloid Cells Targeting Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Myeloid Cells Targeting Therapeutics Headquarters, Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Myeloid Cells Targeting Therapeutics Headquarters and Area Served
        4.3.2 Global Myeloid Cells Targeting Therapeutics Companies Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Myeloid Cells Targeting Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Myeloid Cells Targeting Therapeutics Market Size by Company
        4.5.1 Top Myeloid Cells Targeting Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Myeloid Cells Targeting Therapeutics Revenue by Players (2020, 2021 & 2022)

 5 Global Myeloid Cells Targeting Therapeutics Market Size by Region
    5.1 Global Myeloid Cells Targeting Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Myeloid Cells Targeting Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Myeloid Cells Targeting Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Myeloid Cells Targeting Therapeutics Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Myeloid Cells Targeting Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Myeloid Cells Targeting Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Myeloid Cells Targeting Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Myeloid Cells Targeting Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Myeloid Cells Targeting Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Myeloid Cells Targeting Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Myeloid Cells Targeting Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Myeloid Cells Targeting Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 ChemoCentryx
        7.1.1 ChemoCentryx Company Details
        7.1.2 ChemoCentryx Business Overview
        7.1.3 ChemoCentryx Myeloid Cells Targeting Therapeutics Introduction
        7.1.4 ChemoCentryx Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.1.5 ChemoCentryx Recent Development
    7.2 Daiichi Sankyo
        7.2.1 Daiichi Sankyo Company Details
        7.2.2 Daiichi Sankyo Business Overview
        7.2.3 Daiichi Sankyo Myeloid Cells Targeting Therapeutics Introduction
        7.2.4 Daiichi Sankyo Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.2.5 Daiichi Sankyo Recent Development
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Company Details
        7.3.2 Gilead Sciences Business Overview
        7.3.3 Gilead Sciences Myeloid Cells Targeting Therapeutics Introduction
        7.3.4 Gilead Sciences Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.3.5 Gilead Sciences Recent Development
    7.4 Janssen Biotech
        7.4.1 Janssen Biotech Company Details
        7.4.2 Janssen Biotech Business Overview
        7.4.3 Janssen Biotech Myeloid Cells Targeting Therapeutics Introduction
        7.4.4 Janssen Biotech Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.4.5 Janssen Biotech Recent Development
    7.5 Roche
        7.5.1 Roche Company Details
        7.5.2 Roche Business Overview
        7.5.3 Roche Myeloid Cells Targeting Therapeutics Introduction
        7.5.4 Roche Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.5.5 Roche Recent Development
    7.6 Pfizer
        7.6.1 Pfizer Company Details
        7.6.2 Pfizer Business Overview
        7.6.3 Pfizer Myeloid Cells Targeting Therapeutics Introduction
        7.6.4 Pfizer Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.6.5 Pfizer Recent Development
    7.7 GlaxoSmithKline
        7.7.1 GlaxoSmithKline Company Details
        7.7.2 GlaxoSmithKline Business Overview
        7.7.3 GlaxoSmithKline Myeloid Cells Targeting Therapeutics Introduction
        7.7.4 GlaxoSmithKline Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.7.5 GlaxoSmithKline Recent Development
    7.8 Macrophage Pharma
        7.8.1 Macrophage Pharma Company Details
        7.8.2 Macrophage Pharma Business Overview
        7.8.3 Macrophage Pharma Myeloid Cells Targeting Therapeutics Introduction
        7.8.4 Macrophage Pharma Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.8.5 Macrophage Pharma Recent Development
    7.9 Enlivex
        7.9.1 Enlivex Company Details
        7.9.2 Enlivex Business Overview
        7.9.3 Enlivex Myeloid Cells Targeting Therapeutics Introduction
        7.9.4 Enlivex Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.9.5 Enlivex Recent Development
    7.10 Immune-Onc Therapeutics
        7.10.1 Immune-Onc Therapeutics Company Details
        7.10.2 Immune-Onc Therapeutics Business Overview
        7.10.3 Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Introduction
        7.10.4 Immune-Onc Therapeutics Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.10.5 Immune-Onc Therapeutics Recent Development
    7.11 Infinity Pharmaceuticals
        7.11.1 Infinity Pharmaceuticals Company Details
        7.11.2 Infinity Pharmaceuticals Business Overview
        7.11.3 Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Introduction
        7.11.4 Infinity Pharmaceuticals Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.11.5 Infinity Pharmaceuticals Recent Development
    7.12 AstraZeneca
        7.12.1 AstraZeneca Company Details
        7.12.2 AstraZeneca Business Overview
        7.12.3 AstraZeneca Myeloid Cells Targeting Therapeutics Introduction
        7.12.4 AstraZeneca Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
        7.12.5 AstraZeneca Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Myeloid Cells Targeting Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Myeloid Cells Targeting Therapeutics Market Trends
    Table 3. Myeloid Cells Targeting Therapeutics Market Drivers
    Table 4. Myeloid Cells Targeting Therapeutics Market Challenges
    Table 5. Myeloid Cells Targeting Therapeutics Market Restraints
    Table 6. Global Myeloid Cells Targeting Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Myeloid Cells Targeting Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Myeloid Cells Targeting Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Myeloid Cells Targeting Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Myeloid Cells Targeting Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Myeloid Cells Targeting Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Myeloid Cells Targeting Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Myeloid Cells Targeting Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Myeloid Cells Targeting Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myeloid Cells Targeting Therapeutics as of 2021)
    Table 15. Top Players of Myeloid Cells Targeting Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Myeloid Cells Targeting Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Myeloid Cells Targeting Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Myeloid Cells Targeting Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Myeloid Cells Targeting Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Myeloid Cells Targeting Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Myeloid Cells Targeting Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Myeloid Cells Targeting Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Myeloid Cells Targeting Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Myeloid Cells Targeting Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Myeloid Cells Targeting Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Myeloid Cells Targeting Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Myeloid Cells Targeting Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. ChemoCentryx Company Details
    Table 31. ChemoCentryx Business Overview
    Table 32. ChemoCentryx Myeloid Cells Targeting Therapeutics Product
    Table 33. ChemoCentryx Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. ChemoCentryx Recent Development
    Table 35. Daiichi Sankyo Company Details
    Table 36. Daiichi Sankyo Business Overview
    Table 37. Daiichi Sankyo Myeloid Cells Targeting Therapeutics Product
    Table 38. Daiichi Sankyo Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Daiichi Sankyo Recent Development
    Table 40. Gilead Sciences Company Details
    Table 41. Gilead Sciences Business Overview
    Table 42. Gilead Sciences Myeloid Cells Targeting Therapeutics Product
    Table 43. Gilead Sciences Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Gilead Sciences Recent Development
    Table 45. Janssen Biotech Company Details
    Table 46. Janssen Biotech Business Overview
    Table 47. Janssen Biotech Myeloid Cells Targeting Therapeutics Product
    Table 48. Janssen Biotech Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Janssen Biotech Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche Myeloid Cells Targeting Therapeutics Product
    Table 53. Roche Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Pfizer Company Details
    Table 56. Pfizer Business Overview
    Table 57. Pfizer Myeloid Cells Targeting Therapeutics Product
    Table 58. Pfizer Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. Pfizer Recent Development
    Table 60. GlaxoSmithKline Company Details
    Table 61. GlaxoSmithKline Business Overview
    Table 62. GlaxoSmithKline Myeloid Cells Targeting Therapeutics Product
    Table 63. GlaxoSmithKline Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. GlaxoSmithKline Recent Development
    Table 65. Macrophage Pharma Company Details
    Table 66. Macrophage Pharma Business Overview
    Table 67. Macrophage Pharma Myeloid Cells Targeting Therapeutics Product
    Table 68. Macrophage Pharma Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. Macrophage Pharma Recent Development
    Table 70. Enlivex Company Details
    Table 71. Enlivex Business Overview
    Table 72. Enlivex Myeloid Cells Targeting Therapeutics Product
    Table 73. Enlivex Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. Enlivex Recent Development
    Table 75. Immune-Onc Therapeutics Company Details
    Table 76. Immune-Onc Therapeutics Business Overview
    Table 77. Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Product
    Table 78. Immune-Onc Therapeutics Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 79. Immune-Onc Therapeutics Recent Development
    Table 80. Infinity Pharmaceuticals Company Details
    Table 81. Infinity Pharmaceuticals Business Overview
    Table 82. Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Product
    Table 83. Infinity Pharmaceuticals Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 84. Infinity Pharmaceuticals Recent Development
    Table 85. AstraZeneca Company Details
    Table 86. AstraZeneca Business Overview
    Table 87. AstraZeneca Myeloid Cells Targeting Therapeutics Product
    Table 88. AstraZeneca Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
    Table 89. AstraZeneca Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Myeloid Cells Targeting Therapeutics Product Picture
    Figure 2. Global Myeloid Cells Targeting Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Myeloid Cells Targeting Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Myeloid Cells Targeting Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Myeloid Cells Targeting Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Myeloid Cells Targeting Therapeutics Market Share in Global 2017-2028
    Figure 7. Myeloid Cells Targeting Therapeutics Report Years Considered
    Figure 8. Product Picture of Intravenous Injection
    Figure 9. Product Picture of Oral
    Figure 10. Global Myeloid Cells Targeting Therapeutics Market Share by Type in 2022 & 2028
    Figure 11. Global Myeloid Cells Targeting Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Myeloid Cells Targeting Therapeutics Market Share by Type (2017-2028)
    Figure 13. United States Myeloid Cells Targeting Therapeutics Market Share by Type in 2022 & 2028
    Figure 14. United States Myeloid Cells Targeting Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Myeloid Cells Targeting Therapeutics Market Share by Type (2017-2028)
    Figure 16. Product Picture of Oncological Disorders
    Figure 17. Product Picture of Rare Disorders
    Figure 18. Global Myeloid Cells Targeting Therapeutics Market Share by Application in 2022 & 2028
    Figure 19. Global Myeloid Cells Targeting Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Myeloid Cells Targeting Therapeutics Market Share by Application (2017-2028)
    Figure 21. United States Myeloid Cells Targeting Therapeutics Market Share by Application in 2022 & 2028
    Figure 22. United States Myeloid Cells Targeting Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Myeloid Cells Targeting Therapeutics Market Share by Application (2017-2028)
    Figure 24. North America Myeloid Cells Targeting Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. United States Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Myeloid Cells Targeting Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. China Taiwan Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Latin America Myeloid Cells Targeting Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 44. Mexico Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Brazil Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Argentina Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Colombia Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. UAE Myeloid Cells Targeting Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. ChemoCentryx Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 53. Daiichi Sankyo Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 54. Gilead Sciences Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 55. Janssen Biotech Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 56. Roche Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 59. Macrophage Pharma Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 60. Enlivex Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 61. Immune-Onc Therapeutics Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 62. Infinity Pharmaceuticals Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 63. AstraZeneca Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Market Analysis and Insights: Global and United States Myeloid Cells Targeting Therapeutics Market
This report focuses on global and United States Myeloid Cells Targeting Therapeutics market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Myeloid Cells Targeting Therapeutics market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Intravenous Injection accounting for % of the Myeloid Cells Targeting Therapeutics global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Oncological Disorders was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Myeloid Cells Targeting Therapeutics market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Myeloid Cells Targeting Therapeutics Scope and Market Size
Myeloid Cells Targeting Therapeutics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Myeloid Cells Targeting Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Myeloid Cells Targeting Therapeutics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Intravenous Injection
    Oral

Segment by Application
    Oncological Disorders
    Rare Disorders

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    ChemoCentryx
    Daiichi Sankyo
    Gilead Sciences
    Janssen Biotech
    Roche
    Pfizer
    GlaxoSmithKline
    Macrophage Pharma
    Enlivex
    Immune-Onc Therapeutics
    Infinity Pharmaceuticals
    AstraZeneca